Jutze Intelligent Technology Co Ltd (300802.SZ) stock: key figures, P/E, revenue and dividend
Information Technology · Electronic Components · China · ISIN CNE100003QW9
Jutze Intelligent Technology Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 662.14 m CNY | 773.61 m CNY |
| Gross profit | 176.91 m CNY | 234.25 m CNY |
| Operating income | 71.79 m CNY | 96.96 m CNY |
| EBIT | 74.61 m CNY | 101.05 m CNY |
| Net income | 66.30 m CNY | 89.93 m CNY |
| Diluted EPS – continuing operations | 0.23 CNY | 0.32 CNY |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jutze Intelligent Technology Co Ltd
Jutze Intelligence Technology Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of intelligent equipment and components in China and internationally. It offers machine vision equipment, control cable assemblies, and control units and related equipment. The company's products are used in electronic information manufacturing, industrial control, metallurgy, electronics, new energy, food and packaging, and automobiles industries. It exports its products. The company was founded in 2007 and is headquartered in Shanghai, China.
More stocks
- Guangdong Hongjing Optoelectronic Technology Inc. (301479.SZ)
- Jiangxi Black Cat Carbon Black (002068.SZ)
- Kingsgate Consolidated Ltd (KCN.AX)
- Chongqing Pharscin Pharmaceutical Co Ltd (002907.SZ)
- Karoon Energy Ltd (KAR.AX)
- Wuhan LinControl Automotive Electronics Co. Ltd. A (688667.SS)
- Myson Century, Inc. (5314.TWO)
- Chongqing Road & Bridge Co Ltd (600106.SS)
- Oxford Biomedica PLC (OXB.L)
- R&G PharmaStudies Co. Ltd. A (301333.SZ)
- OSL Group Ltd (863.HK)
- Shandong Senter Electn Co Ltd (001388.SZ)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.